SAGILITY

Sagility Limited presents a compelling narrative in healthcare business process management, strategically positioned within the enduring trend of healthcare outsourcing to India. This provides a stable demand environment, critical for long-term visibility. The financial trajectory is particularly noteworthy: FY25 showcased not just revenue growth, but significantly faster profit expansion, a clear sign of operating leverage and efficiency gains. Crucially, the balance sheet has seen substantial de-risking, with net debt almost halved and leverage ratios dropping sharply. This improved financial health, coupled with strategic investments in AI and machine learning to enhance its offerings, suggests a company moving beyond a speculative "penny stock" label. While its 12.4% ROCE is reasonable for a services business still refining its model, the overall picture suggests a fundamentally improving operation. Analyst's Take: Sagility isn't just another low-priced stock; it's demonstrating genuine operational improvements and financial discipline in a resilient sector. Its progress in profitability, debt reduction, and tech investments makes it a compelling candidate for patient investors with a 2026 horizon, certainly one to watch closely